Journal Club 18.08.24.
Anatomical and functional dichotomy of ocular itch and pain
Anatomical and functional dichotomy of ocular itch and pain
Cheng-Chiu Huang1,7,9, Weishan Yang1,9, Changxiong Guo1, Haowu Jiang1, Fengxian Li 1,2, Maolei Xiao1, Steve Davidson3, Guang Yu 4, Bo Duan5,8, Tianwen Huang5, Andrew J. W. Huang 6 and Qin Liu1,6*
Itch and pain are refractory symptoms of many ocular conditions. Ocular itch is generated mainly in the conjunctiva and is absent from the cornea. In contrast, most ocular pain arises from the cornea. However, the underlying mechanisms remain unknown. Using genetic axonal tracing approaches, we discover distinct sensory innervation patterns between the conjunctiva and cornea. Further genetic and functional analyses in rodent models show that a subset of conjunctival-selective sensory fibers marked by MrgprA3 expression, rather than corneal sensory fibers, mediates ocular itch. Importantly, the actions of both histamine and nonhistamine pruritogens converge onto this unique subset of conjunctiva sensory fibers and enable them to play a key role in mediating itch associated with allergic conjunctivitis. This is distinct from skin itch, in which discrete popu- lations of sensory neurons cooperate to carry itch. Finally, we provide proof of concept that selective silencing of conjunctiva itch-sensing fibers by pruritogen-mediated entry of sodium channel blocker QX-314 is a feasible therapeutic strategy to treat ocular itch in mice. Itch-sensing fibers also innervate the human conjunctiva and allow pharmacological silencing using QX-314. Our results cast new light on the neural mechanisms of ocular itch and open a new avenue for developing therapeutic strategies.
Journal Club 18.08.24. Read More »
S1PR3 mediates inflammatory pain and itch via distinct TRP channel dependent pathways
In this work, we establish a role for the bioactive lipid sphingosine 1-phosphate (S1P) and its
receptor S1PR3 in inflammatory thermal pain and itch. S1P injection elicited robust heat hypersensitivity, acute pain, and itch behaviors in mice, which were wholly dependent on S1PR3. S1P-evoked pain was entirely dependent on TRPV1 ion channels, whereas S1P evoked itch was dependent on TRPA1. Consistent with our in vivo findings, we found that S1P activated subsets of both heat- and itch-sensitive dorsal root ganglion (DRG) neurons, and that activation was solely dependent on S1PR3, and not S1PR1. Our data support a model in which S1P elicits neuronal activation via two pathways in distinct subsets of somatosensory neurons. Gβγ-dependent activation of TRPA1 mediates S1PR3-evoked calcium responses in one subpopulation, whereas PLC-dependent activation of TRPV1 mediates S1PR3-evoked calcium responses in the other subpopulation. In the Complete Freund’s Adjuvant (CFA) -induced inflammatory pain model, S1PR3-deficient mice failed to develop heat hypersensitivity, whereas mechanical hypersensitivity developed normally. Pharmacological blockade of S1PR3 activity or S1P production rapidly and selectively ameliorated heat hypersensitivity in wild-type mice treated with CFA. These data definitively identify S1PR3 as a mediator of thermal pain and itch, and, furthermore, demonstrate for the first time that elevated peripheral S1P is an essential driver of chronic inflammatory pain.
S1PR3 mediates inflammatory pain and itch via distinct TRP channel dependent pathways Read More »
18.07.20
Extracellular signal-regulated kinase (ERK) activation is required for itch sensation in the spinal cord
Background
Itch, chronic itch in particular, can have a significant negative impact on an individual’s quality of life. However, the molecular mechanisms underlying itch processing in the central nervous system remain largely unknown.
2018.06.22
BP180 dysfunction triggers spontaneous skin inflammation in mice.
Abstract
BP180, also known as collagen XVII, is a hemidesmosomal component and plays a key role in maintaining skin dermal/epidermal adhesion. Dysfunction of BP180, either through genetic mutations in junctional epidermolysis bullosa (JEB) or autoantibody insult in bullous pemphigoid (BP), leads to subepidermal blistering accompanied by skin inflammation. However, whether BP180 is involved in skin inflammation remains unknown. To address this question, we generated a BP180-dysfunctional mouse strain and found that mice lacking functional BP180 (termed ΔNC16A) developed spontaneous skin inflammatory disease, characterized by severe itch, defective skin barrier, infiltrating immune cells, elevated serum IgE levels, and increased expression of thymic stromal lymphopoietin (TSLP). Severe itch is independent of adaptive immunity and histamine, but dependent on increased expression of TSLP by keratinocytes. In addition, a high TSLP expression is detected in BP patients. Our data provide direct evidence showing that BP180 regulates skin inflammation independently of adaptive immunity, and BP180 dysfunction leads to a TSLP-mediated itch. The newly developed mouse strain could be a model for elucidation of disease mechanisms and development of novel therapeutic strategies for skin inflammation and BP180-related skin conditions.
BP180 dysfunction triggers spontaneous skin inflammation in mice.
Journal Club 18.06.08.
Persistent Extracellular Signal-Regulated Kinase Activation by the Histamine H4 Receptor in Spinal Neurons Underlies Chronic Itch
Kun Huang1,2,5, Dan-Dan Hu1,3,5, Dong Bai1,2,5, Ze-Yang Wu1,3, Yi-Yang Chen4, Yi-Jun Zhang1,3, Xin Lv4, Qing-Xiu Wang2 and Ling Zhang1,3
Transient extracellular signal-regulated kinase (ERK) activation in the spinal cord triggers histamine-induced acute itch. However, whether persistent ERK activation plays an important role in chronic itch development remains unclear. This study investigated the role of spinal ERK activation in chronic itch. The results showed that repetitive DNFB painting on the nape of mice evoked not only initial scratching but also sustained, spontaneous scratching. In addition, DNFB induced itching rather than nociception, as demonstrated using a cheek model. Furthermore, ERK was persistently activated in the spinal cord of DNFB-treated mice, and the intrathecal inhibition of phosphorylation of ERK suppressed both spontaneous itching and ERK activation. ERK activation was observed in neurons but not in glia cells during chronic itch development. Finally, DNFB- induced spontaneous itching behavior and ERK activation were largely inhibited by the histamine H4 receptor antagonist JNJ7777120 but not by the H1 receptor antagonist chlorpheniramine. Our results indi- cate that persistent ERK activation via the histamine H4 receptor in spinal neurons underlies DNFB-induced chronic itch.
Journal of Investigative Dermatology (2018) -, -e-; doi:10.1016/j.jid.2018.02.019
Journal Club 18.06.08. Read More »
18.06.01
Upregulation of the human alkaline ceramidase 1 and acid ceramidase mediates calcium-induced differentiation of epidermal keratinocytes.
Abstract
Extracellular calcium (Ca2+(o)) potently induces the growth arrest and differentiation of human epidermal keratinocytes (HEKs). We report that Ca2+(o) markedly upregulates the human alkaline ceramidase 1 (haCER1) in HEKs; and its upregulation mediates the Ca2+(o)-induced growth arrest and differentiation of HEKs. haCER1 is the human ortholog of mouse alkaline ceramidase 1 that we previously identified. haCER1 catalyzed the hydrolysis of very long-chain ceramides to generate sphingosine (SPH). This in vitro activity required Ca2+. Ectopic expression of haCER1 in HEKs decreased the levels of D-e-C(24:1)-ceramide and D-e-C(24:0)-ceramide but elevated the levels of both SPH and its phosphate (S1P), whereas RNA interference-mediated knockdown of haCER1 caused the opposite effects on the levels of these sphingolipids in HEKs. Similar to haCER1 overexpression, Ca2+(o) increased the levels of SPH and S1P, and this was attenuated by haCER1 knockdown. haCER1 knockdown also inhibited the Ca2+(o)-induced growth arrest of HEKs and the Ca2+(o)-induced expression of keratin 1 and involucrin in HEKs. In addition, the acid ceramidase (AC) was also upregulated by Ca2+(o); and its knockdown attenuated the Ca2+(o)-induced expression of keratin 1 and involucrin in HEKs. These results strongly suggest that upregulation of haCER1 and AC mediates the Ca2+(o)-induced growth arrest and differentiation of HEKs by generating SPH and S1P.
18.05.25
New mechanism underlying IL-31-induced atopic dermatitis.
Abstract
BACKGROUND:
TH2 cell-released IL-31 is a critical mediator in patients with atopic dermatitis (AD), a prevalent and debilitating chronic skin disorder. Brain-derived natriuretic peptide (BNP) has been described as a central itch mediator. The importance of BNP in peripheral (skin-derived) itch and its functional link to IL-31 within the neuroimmune axis of the skin is unknown.
2018.05.11
Distinct functions of opioid-related peptides and gastrin-releasing peptide in regulating itch and pain in the spinal cord of primates.
Abstract
How neuropeptides in the primate spinal cord regulate itch and pain is largely unknown. Here we elucidate the sensory functions of spinal opioid-related peptides and gastrin-releasing peptide (GRP) in awake, behaving monkeys. Following intrathecal administration, β-endorphin (10-100 nmol) and GRP (1-10 nmol) dose-dependently elicit the same degree of robust itch scratching, which can be inhibited by mu-opioid peptide (MOP) receptor and GRP receptor (BB2) antagonists, respectively. Unlike β-endorphin, which produces itch and attenuates inflammatory pain, GRP only elicits itch without affecting pain. In contrast, enkephalins (100-1000 nmol) and nociceptin-orphanin FQ (3-30 nmol) only inhibit pain without eliciting itch. More intriguingly, dynorphin A(1-17) (10-100 nmol) dose-dependently attenuates both β-endorphin- and GRP-elicited robust scratching without affecting pain processing. The anti-itch effects of dynorphin A can be reversed by a kappa-opioid peptide (KOP) receptor antagonist nor-binaltorphimine. These nonhuman primate behavioral models with spinal delivery of ligands advance our understanding of distinct functions of neuropeptides for modulating itch and pain. In particular, we demonstrate causal links for itch-eliciting effects by β-endorphin-MOP receptor and GRP-BB2 receptor systems and itch-inhibiting effects by the dynorphin A-KOP receptor system. These studies will facilitate transforming discoveries of novel ligand-receptor systems into future therapies as antipruritics and/or analgesics in humans.
Journal Club 18.05.04.
Cooling Relief of Acute and Chronic Itch Requires TRPM8 Channels and Neurons
Radhika Palkar1,3, Serra Ongun1,2, Edward Catich1,3, Natalie Li1, Neil Borad1, Angela Sarkisian1 and David D. McKemy1,2,3
1Neurobiology Section, Department of Biological Sciences, University of Southern California, Los Angeles, California; 2Molecular and Computational Biology Graduate Program, Department of Biological Sciences, University of Southern California, Los Angeles, California; and 3Neuroscience Graduate Program, Department of Biological Sciences, University of Southern California, Los Angeles, California
Correspondence: David D. McKemy, Neurobiology Section, Department of Biological Sciences, University of Southern California, 3641 Watt Way, HNB 201, Los Angeles, CA 90089. E-mail: mckemy@dornsife.usc.edu
Abbreviations: Cqx, chloroquine; a-Me5-HT, a-methyl 5-HT
Received 16 August 2017; revised 8 December 2017; accepted 20 December 2017; accepted manuscript published online 27 December 2017; corrected proof published online XXX
Cooling Relief of Acute and Chronic Itch Requires TRPM8 Channels and Neurons
Cooling or the application of mentholated liniments to the skin has been used to treat itch for centuries, yet remarkably little is known about how counter-stimuli such as these induce itch relief. Indeed, there is no clear consensus in the scientific literature as to whether or not cooling does in fact block the transduction of itch signals or if it is simply a placebo effect. This gap in our understanding led us to hypothesize that cooling is antipruritic and, like cooling analgesia, requires function of the cold-gated ion channel TRPM8, a receptor for menthol expressed on peripheral afferent nerve endings. Using a combination of pharmacologic, genetic, and mouse behavioral assays, we find that cooling inhibits both histaminergic and non-histaminergic itch pathways, and that inhibition of itch by cooling requires TRPM8 channels or intact and functional TRPM8-expressing afferent neurons. The cold mimetic menthol is also effective in ameliorating itch in a TRPM8-dependent manner. Moreover, we find that chronic itch can be ameliorated by cooling, demonstrating that this counter-stimulus activates a specific neural circuit that leads to broad itch relief and a potential cellular mechanism for treatment of chronic itch.
Journal of Investigative Dermatology (2018) -, -e-; doi:10.1016/j.jid.2017.12.025
Journal Club 18.05.04. Read More »